VO2peak prior to transplant differentiates survival post kidney transplant

被引:5
|
作者
Chakkera, Harini A. [1 ]
Kaplan, Bruce [2 ]
Budhiraja, Pooja [1 ]
Behmen, Senaida [1 ]
Fitz-Patrick, Dennis [3 ]
Butterfield, Richard J. [4 ]
机构
[1] Mayo Clin, Div Nephrol, Phoenix, AZ USA
[2] Univ Colorado, CCTCARE, Aurora, CO USA
[3] Mayo Clin, Dept Res, Phoenix, AZ USA
[4] Mayo Clin, Div Biomed Stat & Informat, Phoenix, AZ USA
关键词
exercise capacity; frailty; mortality; EXERCISE; PREDICTOR; MORTALITY; CAPACITY; FRAILTY;
D O I
10.1111/ctr.14517
中图分类号
R61 [外科手术学];
学科分类号
摘要
The OPTN/UNOS utilizes the calculated estimated posttransplant survival (EPTS) score as the measure of post-kidney transplant survival to guide allocation of deceased donor kidney transplantation. This score does not include any metric of functional capacity. Peak oxygen uptake (VO2peak), is an established predictor of survival among both the general and diseased populations. We assessed the association and discriminative capacity of VO2peak and that of EPTS score and all-cause mortality post-kidney transplant. Additionally, we assessed the "mortality risk" lower VO2peak conferred on those patients with low EPTS score. Among a cohort of 293 transplant recipients with at least 3-years post-transplant follow-up, the median VO2peak was 15.0 ml/Kg/min. Lower pre-transplant VO2peak and higher EPTS score conferred higher risk of post-transplant mortality. Among the cohort of "low-risk" patients (patients with EPTS score < 50) those with lower VO2peak had significantly higher risk of mortality (log rank p = 0.045). In fact, the mortality risk among those with low-EPTS (< 50) and low VO2peak < 12 ml/Kg/min was equivalent to those with high EPTS (> 80) score. We concluded functional capacity as defined by VO2peak is an important reflection of post-transplant survival. VO2peak is able to identify those with low EPTS who have similar survival to that of high EPTS phenotype.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] VO2peak Differentiates Survival Post Kidney Transplant
    Chakkera, H.
    Kaplan, B.
    Budhiraja, P.
    Butterfield, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 645 - 646
  • [2] Vo2peak Superior to Current Established Measure of Post Kidney Transplant Survival Score (EPTS Score).
    Chakkera, H.
    Butterfield, R.
    Buras, M.
    Kaplan, B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 548 - 548
  • [3] Post-Transplant VO2peak, It's Time for a New Standard!
    Schnegg, B.
    Bruno, J.
    Wilhelm, M.
    Brugger, N.
    Munsch, L. C. Hunziker
    Martinelli, M.
    Georgios, S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (04): : S203 - S203
  • [4] Clinical features and determinants of VO2peak in de novo heart transplant recipients
    Katrine Rolid
    Arne K Andreassen
    Marianne Yardley
    Elisabeth Bj?rkelund
    Kristjan Karason
    Julia P Wigh
    Christian H Dall
    Finn Gustafsson
    Lars Gullestad
    Kari Nytr?en
    World Journal of Transplantation, 2018, 8 (05) : 188 - 197
  • [5] Muscular exercise capacity and body fat predict VO2peak in heart transplant recipients
    Nytroen, Kari
    Rustad, Lene Annette
    Gude, Einar
    Hallen, Jostein
    Fiane, Arnt E.
    Rolid, Katrine
    Holm, Inger
    Aakhus, Svend
    Gullestad, Lars
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2014, 21 (01) : 21 - 29
  • [6] Changes in Peak Oxygen Uptake (VO2peak) Following Renal Transplant: Results after 3-year Follow-up
    Bushroe, Cody M.
    Chakkera, Harini A.
    Angadi, Siddhartha S.
    FASEB JOURNAL, 2018, 32 (01):
  • [7] Clinical VO2peak is "part of the deal"
    van Breda, Eric
    Schoffelen, Paul F. M.
    Plasqui, Guy
    JOURNAL OF APPLIED PHYSIOLOGY, 2017, 122 (05) : 1370 - 1370
  • [8] Changes in peak oxygen uptake (VO2peak) following renal transplant: Results after 3-year follow-up
    Angadi, Siddhartha S.
    Bushroe, Cody M.
    Chakkera, Harini A.
    TRANSLATIONAL SPORTS MEDICINE, 2021, 4 (06) : 845 - 848
  • [9] VO2peak: A Significant Marker of All-Cause Mortality Among Patients with End-Stage Renal Disease Being Evaluated for Kidney Transplant
    Chakkera, H.
    Temkit, M.
    Kaplan, B.
    Gaesser, G.
    Heilman, R.
    Khamash, H.
    Reddy, K.
    Steidley, E.
    Mathur, A.
    Nair, S.
    Mour, G.
    Huskey, J.
    Moss, A.
    Singer, A.
    Hewitt, W.
    Qaqish, I.
    Behmen, S.
    Angadi, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 329 - 330
  • [10] Amiodarone Use Prior to Cardiac Transplant Impacts Early Post-Transplant Survival
    Salman S. Allana
    Furqan A. Rajput
    Jason W. Smith
    Lucian Lozonschi
    Jinn-ing Liou
    Maryl Johnson
    Takushi Kohmoto
    Ravi Dhingra
    Cardiovascular Drugs and Therapy, 2021, 35 : 33 - 40